Alex Oh

Alex Oh joined Dynavax in 2022 and currently serves as Vice President, Intellectual Property and Associate General Counsel. Before joining Dynavax, Mr. Oh served as Vice President, Legal & IP at Visus Therapeutics, Inc. and as Senior Counsel at Juno Therapeutics, a Bristol Myers Squibb Company, where he led global IP strategy, managed patent procurement and portfolios, handled administrative proceedings, negotiated complex IP and corporate transactions, and oversaw external partnerships and collaborations. Previously, Mr. Oh was a Partner in the Technology & Intellectual Property group at Stoel Rives LLP, where he advised clients on global IP strategy, procurement and portfolio management, IP litigation and administrative proceedings, IP licensing, acquisitions and divestitures, patent infringement and validity analysis, and due diligence evaluations for corporate transactions. While at Stoel Rives, Mr. Oh also served as an Affiliate Instructor of Law at the University of Washington School of Law.

Mr. Oh holds a J.D. from the University of Wisconsin Law School, an M.S. in Biotechnology from the University of Wisconsin School of Medicine and Public Health, and a B.S. in Neurobiology and a B.A. in Communication from the University of Washington.